GUTS — FRACTYL HEALTH, INC.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1572616 ·
Last close
$0.47
Market Cap
$74.97M
52W High
$2.44
52W Low
$0.38
ADV30
1,683,077
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | 0 | -19,096,000 | -25,538,000 | 81,976,000 | 47,140,000 | 83,641,000 |
| Mar 2026 | 0 | — | -20,820,000 | 9,218,000 | 99,385,000 | 63,168,000 | 78,008,000 |
| Dec 2025 | 0 | 0 | -23,284,000 | -43,727,000 | 121,402,000 | 81,540,000 | 111,944,000 |
| Sep 2025 | 0 | 0 | -22,694,000 | -45,603,000 | 114,272,000 | 77,657,000 | 117,450,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-87,726,000
Investing CF
$-109,000
Financing CF
$108,895,000
CapEx
$-557,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-1.49
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-547,046,000
Inventory
$0
Receivables
$0
ST Investments
—
EBIT TTM
$-92,877,000
Pretax Income TTM
$-108,001,000
Interest Exp TTM
—
Analysts
6
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -96,816,000 | -140,954,000 | 121,402,000 | 111,944,000 | 9,458,000 | -90,328,000 |
| Dec 2024 | 93,000 | -93,531,000 | -68,694,000 | 108,077,000 | 79,653,000 | 28,424,000 | -65,521,000 |
| Dec 2023 | 120,000 | -50,836,000 | -77,091,000 | 76,212,000 | 401,274,000 | -325,062,000 | -42,823,000 |
| Dec 2022 | 0 | -49,385,000 | -46,453,000 | 60,956,000 | 313,275,000 | -252,319,000 | -46,243,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.44
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| RTGN | RetinalGenix Technologies Inc. | $75.19M | $3.99 | — |
| HYPR | Hyperfine, Inc. | $76.06M | $0.84 | — |
| RNXT | RenovoRx, Inc. | $69.95M | $1.55 | — |
| CVRX | CVRx, Inc. | $69.00M | $2.59 | — |
| STEX | Streamex Corp. | $82.08M | $0.70 | — |
News headlines (Yahoo Finance, 1h cache)
Fractyl Health to Participate in Upcoming September Investor Conferences
2026-09-09 11:00 · Yahoo
Fractyl Health Eyes 2028 Revita Launch for Post-GLP-1 Weight Maintenance
2026-09-01 21:01 · Yahoo
Fractyl Health shares rise 2.8% ahead of Virtual Commercial Strategy Day
2026-09-01 12:56 · Yahoo
Fractyl Health to Host Virtual Commercial Strategy Day on Tuesday, September 1, 2026: The Potential Path to Commercializing Revita®, a Procedural Therapy for Post-GLP-1 Weight Maintenance
2026-08-20 11:00 · Yahoo
Fractyl Health Eyes Q4 Revita Data, Launches Rejuva Gene Therapy Trial
2026-08-14 09:04 · Yahoo
Fractyl Health Inc (GUTS) (Q2 2026) Earnings Call Highlights: Pivotal Data on Track and ...
2026-08-11 05:03 · Yahoo
Fractyl Health Q2 Earnings Call Highlights
2026-08-10 23:04 · Yahoo
Fractyl Health Reports Second Quarter 2026 Financial Results and Business Updates
2026-08-10 20:05 · Yahoo
Fractyl Health to Report Second Quarter 2026 Financial Results and Provide Business Updates on August 10, 2026
2026-08-03 20:05 · Yahoo
Fractyl Health to Participate in Upcoming Investor Events
2026-07-22 20:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.